Casdin Eli

CIK 000153426415 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001534264

Recent Transactions

50 trades

Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share
2025-12-04$1.45/sh+150,000→ 72,100,000 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share
2025-12-03$1.44/sh+75,000→ 71,950,000 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share
2025-12-02$1.42/sh+125,000→ 71,875,000 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share
2025-11-25$1.30/sh+7,550,000→ 71,750,000 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share
2025-11-24$1.43/sh+150,000→ 64,200,000 total
Sale
BIOLIFE SOLUTIONS INC$BLFS
Common Stock, par value $0.001 per share
2025-08-15$24.40/sh−500,000→ 6,707,165 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-27$2.19/sh+250,000→ 54,025,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-26$2.15/sh+150,000→ 53,775,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-23$2.13/sh+292,100→ 53,625,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-22$1.96/sh+307,900→ 53,333,721 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-21$1.90/sh+500,000→ 53,025,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-20$1.87/sh+500,000→ 52,525,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-19$1.85/sh+250,000→ 52,025,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-14$1.59/sh+1,200,000→ 51,775,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-13$1.62/sh+550,000→ 50,575,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-12$1.64/sh+500,000→ 50,025,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-09$1.61/sh+525,408→ 49,525,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-08$1.64/sh+569,562→ 49,000,413 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-07$1.57/sh+500,000→ 48,430,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-05$1.58/sh+200,000→ 47,930,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-08-02$1.63/sh+1,000,000→ 47,730,821 total
Other
GeneDx Holdings Corp.$WGS
Class A Common Stock
2024-08-01$32.25/sh+413,655→ 3,507,164 total
Award
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-07-19+1,588→ 2,752,332 total
Award
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-06-28+43,128→ 2,750,744 total
Award
STANDARD BIOTOOLS INC.$LAB
Stock Option (Right to buy)
2024-06-28+72,213→ 72,213 total
Award
GeneDx Holdings Corp.$WGS
Restricted Stock Unit
2024-06-26+12,924→ 12,924 total
Exercise/Conversion
GeneDx Holdings Corp.$WGS
Restricted Stock Unit
2024-06-20−5,828→ 0 total
Exercise/Conversion
GeneDx Holdings Corp.$WGS
Class A Common Stock
2024-06-20+5,828→ 7,593 total
Other
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-06-18$2.05/sh−1,200,000→ 0 total
Other
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-06-18$2.05/sh+655,000→ 46,730,821 total
Other
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-06-18$2.05/sh+545,000→ 545,000 total
Award
2seventy bio, Inc.
Stock Options (Right to buy)
2024-06-10$3.93/sh+12,050→ 12,050 total
Award
2seventy bio, Inc.
Common Stock, par value $0.0001 per share
2024-06-10+6,025→ 22,625 total
Purchase
GeneDx Holdings Corp.$WGS
Class A Common Stock
2024-06-04$22.52/sh+30,000→ 3,093,509 total
Purchase
GeneDx Holdings Corp.$WGS
Class A Common Stock
2024-06-03$20.82/sh+100,000→ 3,063,509 total
Purchase
GeneDx Holdings Corp.$WGS
Class A Common Stock
2024-05-29$21.07/sh+40,000→ 2,963,509 total
Purchase
GeneDx Holdings Corp.$WGS
Class A Common Stock
2024-05-28$20.61/sh+18,304→ 2,923,509 total
Purchase
GeneDx Holdings Corp.$WGS
Class A Common Stock
2024-05-24$20.12/sh+144,196→ 2,905,205 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-05-23$2.60/sh+100,000→ 46,075,821 total
Purchase
GeneDx Holdings Corp.$WGS
Class A Common Stock
2024-05-23$19.59/sh+7,500→ 2,761,009 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-05-22$2.58/sh+150,000→ 45,975,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-05-21$2.56/sh+350,000→ 45,825,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-05-20$2.58/sh+100,000→ 45,475,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-05-17$2.56/sh+352,072→ 45,375,821 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-05-16$2.54/sh+500,000→ 45,023,749 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2024-05-15$2.57/sh+500,000→ 44,523,749 total
Purchase
GeneDx Holdings Corp.$WGS
Class A Common Stock
2024-05-13$23.31/sh+50,000→ 2,753,509 total
Other
BIOLIFE SOLUTIONS INC$BLFS
Common Stock, par value $.001 per share
2024-04-30$17.54/sh−150,000→ 0 total
Other
BIOLIFE SOLUTIONS INC$BLFS
Common Stock, par value $.001 per share
2024-04-30$17.54/sh+150,000→ 8,707,165 total
Purchase
2seventy bio, Inc.
Common Stock, par value $0.0001 per share
2024-03-26$5.10/sh+40,000→ 2,000,000 total

Companies

Recent Filings

Address

1350 AVENUE OF THE AMERICAS SUITE 2405

NEW YORK, NY, 10019

View on SEC.gov